Nanotechnological approaches for the delivery of macromoleculesDaan J.A Crommelin; Gert Storm; Wim Jiskoot; Robert Stenekes; Enrico Mastrobattista; Wim E Hennink · 2003

Recombinant gelatin hydrogels for the sustained release of proteinsMarc Sutter; Juergen Siepmann; Wim E. Hennink; Wim Jiskoot · 2007

Shifting paradigms: biopharmaceuticals versus low molecular weight drugsDaan J.A. Crommelin; Gert Storm; Ruud Verrijk; Leo de Leede; Wim Jiskoot; Wim E. Hennink · 2003

Protein Instability in Poly(Lactic-co-Glycolic Acid) MicroparticlesMarco van de Weert; Wim E. Hennink; Wim Jiskoot · 2000

Chitosan-based delivery systems for protein therapeutics and antigensMaryam Amidi; Enrico Mastrobattista; Wim Jiskoot; Wim E. Hennink · 2010

Molecular structure of dextran sulphate sodium in aqueous environmentYu, Miao; Every, Hayley A.; Jiskoot, Wim; Witkamp, Geert-Jan; Buijs, Wim · Journal of Molecular Structure · 2017

Immunogenicity of meningococcal PorA formulations encapsulated in biodegradable microspheresCarmen Arigita; Joost van den Berg; Karin Wensink; Mies van Steenbergen; Wim E Hennink; Daan J.A Crommelin; Gideon F.A Kersten; Wim Jiskoot · 2004

Oxidation of Recombinant Human Interleukin-2 by Potassium PeroxodisulfateJenny A. Cadée; Mies J. van Steenbergen; Cees Versluis; Albert J. R. Heck; Willy J. M. Underberg; Willem den Otter; Wim Jiskoot; Wim E. Hennink · 2001

Pharmaceutical profiling in drug discovery for lead selection[edited by] Ronald T. Borchardt ... [et al.]. · AAPS Press · 2004

PHARMACOKINETICS IN DRUG DEVELOPMENT VOLUME 2:REGULATORY AND DEVELOPMENT PARADIGMSPETER L.BONATE DANNY R.HOWARD · AAPS PRESS · 2004

PHARMACOKINETICS IN DRUG DEVELOPMENT VOLUME 1:CLINICAL STUDY DESIGN AND ANALYSISPETER L.BONATE DANNY R.HOWARD · AAPS PRESS · 2004